Late phase drug development

Friday, May 3, 2019: 5:30 PM-7:00 PM
Room: 710 (Palais des congres de Montreal)
5:30 PM
212.223
223 A Phase 2 Randomized, Placebo-Controlled Trial of Intranasal Oxytocin in Adults with Autism Spectrum Disorder
E. Anagnostou J. A. Brian J. Goldberg S. Prat L. Capano A. Iaboni A. Solish D. Frisch R. Hastie Adams L. Genore I. Patriciu F. Tran M. Woodbury-Smith
See more of: Late Phase Drug Development
<< Previous Panel | Next Panel >>